SkinMedica

A benchmark in American dermatology and a pioneer in growth factor anti-aging. Centered around growth factor skincare at its core, SkinMedica has dedicated over two decades to scientific research, crafting a full range of advanced anti-aging solutions, including iconic regenerative serums.

Founded in 1999 by dermatologist Dr. Richard Fitzpatrick, this professional U.S. clinical cosmeceutical brand is now part of Allergan Aesthetics. It remains a staple functional anti-aging brand recommended year-round by medical aesthetic institutions and dermatology clinics across North America and Europe, widely celebrated as the founding pioneer of growth factor skincare.

Unlike mainstream skincare that prioritizes synthetic fragrances and sensory texture, SkinMedica has adhered strictly to evidence-based medicine since its inception. Every formulation is backed by clinical trials and patented technology, supported by over 50 U.S. patents and more than a hundred peer-reviewed journal publications. Committed solely to high-performance skincare that delivers visible, transformative results, its products were originally sold exclusively through physician channels, making it a genuine clinical-grade anti-aging benchmark.

Its most groundbreaking breakthrough was the development of the patented TNS® (Tissue Nutrient Solution) complex—pioneering the application of stabilized growth factors in topical skincare and opening a whole new frontier for topical anti-aging therapy.